Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the third quarter ending September 30, 2013 on Wednesday, November 6, 2013, after the U.S. financial markets close.
Management will provide an update on the company, discuss third quarter results, and discuss expectations for the future via conference call on Wednesday, November 6, 2013 at 4:30 p.m. ET.
Help employers find you! Check out all the jobs and post your resume.
